Cargando…

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation

INTRODUCTION AND OBJECTIVES: The risk of ventricular arrhythmia and heart failure in patients with hypertrophic obstructive cardiomyopathy (HOCM) is much higher than that in the general population. More and more pieces of evidence showed that HOCM is the leading cause of sudden cardiac death in youn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Xiangbin, Wang, Wen-yao, Gao, Jun, Zhang, Kuo, Zheng, Jilin, Wang, Jing-jia, Liu, YuPeng, Shao, Chunli, Tang, Yi-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964041/ https://www.ncbi.nlm.nih.gov/pubmed/35360040 http://dx.doi.org/10.3389/fcvm.2022.755376

Ejemplares similares

Alcohol Septal Ablation or Septal Myectomy? An Updated Systematic Review and Meta-Analysis of Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
por: Zheng, Xifeng, et al.
Publicado: (2022)

Thoracoscopic Trans-mitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in the Elderly
por: Wei, Peijian, et al.
Publicado: (2022)

Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy
por: Sun, Jiejun, et al.
Publicado: (2022)

Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
por: Yang, Qiulan, et al.
Publicado: (2021)

Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy
por: Bougioukas, Ioannis, et al.
Publicado: (2016)

Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy
por: Meng, Xiangbin, et al.
Publicado: (2020)

Improvement in coronary microvascular dysfunction evaluated by cardiac magnetic resonance in patients with hypertrophic obstructive cardiomyopathy after transapical beating-heart septal myectomy
por: Zhao, Yun, et al.
Publicado: (2023)

Triglyceride–Glucose Index Independently Predicts New-Onset Atrial Fibrillation After Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy Beyond the Traditional Risk Factors
por: Wei, Zhipeng, et al.
Publicado: (2021)

Septal Thickness Does Not Impact Outcome After Hypertrophic Obstructive Cardiomyopathy Surgery (Septal Myectomy and Subvalvular Mitral Apparatus Remodeling): A 15-Years of Experience
por: Raffa, Giuseppe M., et al.
Publicado: (2022)

Extended myectomy in the treatment of patients with hypertrophic obstructive cardiomyopathy
por: Kuć, Mateusz, et al.
Publicado: (2016)

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy
por: Bogachev-Prokophiev, A, et al.
Publicado: (2015)

Impact of septal myectomy on diastolic function in patients with obstructive hypertrophic cardiomyopathy
por: Yang, Qiulan, et al.
Publicado: (2021)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Liu, Qiang, et al.
Publicado: (2021)

Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
por: Bytyçi, Ibadete, et al.
Publicado: (2020)

First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy
por: Wang, Zihao, et al.
Publicado: (2022)

Significance and Determinants of Plasma Apelin in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2022)

Virtual surgical myectomy as a planning tool for obstructive hypertrophic cardiomyopathy
por: Menon, Prahlad G, et al.
Publicado: (2016)

Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathy
por: Yamabe, Tsuyoshi, et al.
Publicado: (2022)

Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
por: Frustaci, Andrea, et al.
Publicado: (2023)

Genetically Determined Lifestyle and Cardiometabolic Risk Factors Mediate the Association of Genetically Predicted Age at Menarche With Genetic Predisposition to Myocardial Infarction: A Two-Step, Two-Sample Mendelian Randomization Study
por: Zheng, Jilin, et al.
Publicado: (2022)

Preoperative myocardial fibrosis is associated with worse survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: A delayed enhanced cardiac magnetic resonance study
por: Chen, Youzhou, et al.
Publicado: (2022)

Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
por: See, Vincent Y., et al.
Publicado: (2023)

Minimally Invasive Trans-Mitral Septal Myectomy to Treat Hypertrophic Obstructive Cardiomyopathy
por: Kim, Hong Rae, et al.
Publicado: (2015)

Comparison of Modified With Classic Morrow Septal Myectomy in Treating Hypertrophic Obstructive Cardiomyopathy
por: Song, Bangrong, et al.
Publicado: (2016)

Surgery for Hypertrophic Obstructive Cardiomyopathy: Comprehensive LVOT Management beyond Septal Myectomy
por: Affronti, Alessandro, et al.
Publicado: (2021)

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: El Masry, Hicham, et al.
Publicado: (2008)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Influence of operator volume on early outcomes of septal myectomy for isolated hypertrophic obstructive cardiomyopathy
por: Li, Haojie, et al.
Publicado: (2021)

Endocardial Radiofrequency Ablation vs. Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis
por: Jiang, Tao, et al.
Publicado: (2022)

Tips for Successful Septal Myectomy in Patients with Hypertrophic Cardiomyopathy
por: Kim, Jae Hyun
Publicado: (2018)

Targeting Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy Candidates for Surgical Myectomy: Added Value of Three-Dimensional Intracoronary Myocardial Contrast Echocardiography
por: La Canna, Giovanni, et al.
Publicado: (2021)

A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China
por: Wang, Shuiyun, et al.
Publicado: (2013)

Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Nie, Changrong, et al.
Publicado: (2021)

Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2021)

Effects of septal myectomy on left atrial and left ventricular function in obstructive hypertrophic cardiomyopathy
por: Ha, Kyung Eun, et al.
Publicado: (2023)

Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Yanhai, et al.
Publicado: (2021)

Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
por: Scholtz, Smita, et al.
Publicado: (2023)

Pressure Tracings in Hypertrophic Cardiomyopathy With Dynamic Midventricular Obstruction
por: Jung, Hee-Chan, et al.
Publicado: (2012)

Novel Resectable Myocardial Model Using Hybrid Three-Dimensional Printing and Silicone Molding for Mock Myectomy for Apical Hypertrophic Cardiomyopathy
por: Kim, Wooil, et al.
Publicado: (2021)

Catheter ablation in Asian patients with atrial fibrillation and hypertrophic cardiomyopathy: electrophysiological characteristics of recurrence and long-term clinical outcomes
por: Lin, Chih-Hsien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4bmvuium0qti904ek1986b66dr